McGuire Investment Group LLC Reduces Holdings in SPDR S&P Biotech ETF (XBI)

McGuire Investment Group LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 118,326 shares of the exchange traded fund’s stock after selling 860 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 3.5% of McGuire Investment Group LLC’s investment portfolio, making the stock its 6th largest position. McGuire Investment Group LLC owned 0.24% of SPDR S&P Biotech ETF worth $10,713,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Hudock Capital Group LLC bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at about $157,000. Strategic Financial Services Inc raised its holdings in shares of SPDR S&P Biotech ETF by 122.4% in the first quarter. Strategic Financial Services Inc now owns 110,454 shares of the exchange traded fund’s stock valued at $10,001,000 after acquiring an additional 60,797 shares in the last quarter. CWM LLC raised its holdings in shares of SPDR S&P Biotech ETF by 24.9% in the first quarter. CWM LLC now owns 11,034 shares of the exchange traded fund’s stock valued at $999,000 after acquiring an additional 2,198 shares in the last quarter. Deltec Asset Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at about $1,947,000. Finally, Cornell Pochily Investment Advisors Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at about $236,000.

Shares of XBI stock traded up $2.40 on Tuesday, hitting $86.92. The stock had a trading volume of 6,682,578 shares, compared to its average volume of 4,954,248. SPDR S&P Biotech ETF has a one year low of $64.38 and a one year high of $101.55.

TRADEMARK VIOLATION WARNING: “McGuire Investment Group LLC Reduces Holdings in SPDR S&P Biotech ETF (XBI)” was posted by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.com-unik.info/2019/04/23/mcguire-investment-group-llc-reduces-holdings-in-spdr-sp-biotech-etf-xbi.html.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also: What moving averages are used to define a golden cross?

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit